Top Markets
#1 EXOD EXOD +22.08%
#2 Status Status +13.35%
#3 aelf aelf +9.22%
#4 Gas Gas +5.60%
#5 Tornado Cash Tornado Cash +5.29%
#6 BCGame Coin BCGame Coin +4.98%
#7 B3 (Base) B3 (Base) +4.39%
#8 Fake World Assets Fake World Assets +4.11%
#9 The Black Bull The Black Bull +3.94%
#10 aPriori aPriori +3.79%
Coin of the day
EXOD EXOD
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
TaiRx, Inc. TaiRx, Inc.

TaiRx, Inc.

6580
Rang in Aktien #25843
TaiRx, Inc., established in 2011 and headquartered in Taipei City, Taiwan, is a... TaiRx, Inc., established in 2011 and headquartered in Taipei City, Taiwan, is a pharmaceutical company dedicated to the research, development, and commercialization of therapeutic solutions for cancer and other diseases. The company's clinical pipeline includes CVM-1118, an oral anti-cancer drug currently undergoing Phase II clinical trials, and Rexis, an add-on injection therapy for sepsis patients, which is in Phase III trials. In its pre-clinical stage, TaiRx is developing TRX-711 for secondary hyperparathyroidism, TRX-920 as an oral delivery formulation, and TRX-105, a molecule designed to treat and alleviate symptoms of various types of colitis. Beyond its developmental drugs, TaiRx also offers Zelnite, a medication that helps maintain patients' blood selenium levels and supports their immune systems. The company's future endeavors also involve the development of nodal diagnostic devices and innovative antibody-based drugs.
Aktienkurs
$0.40861751
Zuletzt synchronisiert: 2026-08-20
Marktkapitalisierung
$45.81M
Veränderung (1 Tag)
-1.15%
Veränderung (1 Jahr)
-45.04%
Land
TW
Handel TaiRx, Inc. (6580)

Kategorie

Healthcare
Kursverlauf für TaiRx, Inc. (6580)
Höchster Schlusskurs: $0.42 am 2026-08-01

Niedrigster Schlusskurs: $1.41 am 2017-06-01
Kursverlauf der Aktie von TaiRx, Inc. von 2017 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) -13.14%
2025 -14.32%
2024 -0.12%
2023 -32.09%
2022 -18.00%
2021 52.04%
2020 57.15%
2019 -14.81%
2018 -18.47%
2017 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $539.14 35.65%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.04K 56.21%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $120.74 -16.83%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $761.87 8.65%
CH
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $130.43 397.46%
US